How similar are those molecules after all? Use two descriptors and you will have three different answers
暂无分享,去创建一个
[1] Nam Doo Kim,et al. Pharmacophore-based virtual screening: a review of recent applications , 2010, Expert opinion on drug discovery.
[2] Michael F. Lynch,et al. Analysis of Structural Characteristics of Chemical Compounds in the Common Data Base , 1973 .
[3] Anshuman Dixit,et al. Computer-Aided Drug Design: Integration of Structure-Based and Ligand-Based Approaches in Drug Design , 2007 .
[4] R. Glen,et al. Molecular similarity: a key technique in molecular informatics. , 2004, Organic & biomolecular chemistry.
[5] Robert P Sheridan,et al. Why do we need so many chemical similarity search methods? , 2002, Drug discovery today.
[6] Robert P. Sheridan,et al. Comparison of Topological, Shape, and Docking Methods in Virtual Screening , 2007, J. Chem. Inf. Model..
[7] Naomie Salim,et al. Similarity‐Based Virtual Screening with a Bayesian Inference Network , 2009, ChemMedChem.
[8] Hanna Geppert,et al. Current Trends in Ligand-Based Virtual Screening: Molecular Representations, Data Mining Methods, New Application Areas, and Performance Evaluation , 2010, J. Chem. Inf. Model..
[9] Andrew C. Good,et al. Measuring CAMD technique performance: A virtual screening case study in the design of validation experiments , 2004, J. Comput. Aided Mol. Des..
[10] José L. Medina-Franco,et al. Scaffold Diversity Analysis of Compound Data Sets Using an Entropy-Based Measure , 2009 .
[11] A. Bender,et al. Assessment of structural diversity in combinatorial synthesis. , 2005, Current opinion in chemical biology.
[12] Andreas Bender,et al. Similarity Searching of Chemical Databases Using Atom Environment Descriptors (MOLPRINT 2D): Evaluation of Performance , 2004, J. Chem. Inf. Model..
[13] Jérôme Hert,et al. Comparison of Fingerprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures , 2004, J. Chem. Inf. Model..
[14] Eugen Lounkine,et al. Improving the Search Performance of Extended Connectivity Fingerprints through Activity‐Oriented Feature Filtering and Application of a Bit‐Density‐Dependent Similarity Function , 2009, ChemMedChem.
[15] Dudley H Williams,et al. Noncovalent interactions: defining cooperativity. Ligand binding aided by reduced dynamic behavior of receptors. Binding of bacterial cell wall analogues to ristocetin A. , 2004, Journal of the American Chemical Society.
[16] W. Graham Richards,et al. Ultrafast shape recognition to search compound databases for similar molecular shapes , 2007, J. Comput. Chem..
[17] Andreas Bender,et al. Prospective Validation of a Comprehensive In silico hERG Model and its Applications to Commercial Compound and Drug Databases , 2010, ChemMedChem.
[18] John D. Holliday,et al. The effect of structural redundancy in validation sets on virtual screening performance , 2009 .
[19] R. Glen,et al. Screening for Dihydrofolate Reductase Inhibitors Using MOLPRINT 2D, a Fast Fragment-Based Method Employing the Naïve Bayesian Classifier: Limitations of the Descriptor and the Importance of Balanced Chemistry in Training and Test Sets , 2005, Journal of biomolecular screening.
[20] Sebastian G. Rohrer,et al. Maximum Unbiased Validation (MUV) Data Sets for Virtual Screening Based on PubChem Bioactivity Data , 2009, J. Chem. Inf. Model..
[21] Roberto Todeschini,et al. Handbook of Molecular Descriptors , 2002 .
[22] Thomas Sander,et al. Comparison of Ligand- and Structure-Based Virtual Screening on the DUD Data Set , 2009, J. Chem. Inf. Model..
[23] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[24] Walter Filgueira de Azevedo,et al. Drug-binding databases. , 2008, Current drug targets.
[25] I. Kuntz,et al. Molecular similarity based on DOCK-generated fingerprints. , 1996, Journal of medicinal chemistry.
[26] Michael F. Lynch,et al. Analysis of structural characteristics of chemical compounds in a large computer-based file. Part II. Atom-centred fragments , 1970 .
[27] Pekka Tiikkainen,et al. Critical Comparison of Virtual Screening Methods against the MUV Data Set , 2009, J. Chem. Inf. Model..
[28] P. Willett,et al. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. , 2004, Organic & biomolecular chemistry.
[29] Michael J. Sorich,et al. Comparison Data Sets for Benchmarking QSAR Methodologies in Lead Optimization , 2009, J. Chem. Inf. Model..
[30] Markus H. J. Seifert,et al. Essential factors for successful virtual screening. , 2008, Mini reviews in medicinal chemistry.
[31] Jürgen Bajorath,et al. Molecular Fingerprint Recombination: Generating Hybrid Fingerprints for Similarity Searching from Different Fingerprint Types , 2009, ChemMedChem.
[32] Dennis M. Krüger,et al. Comparison of Structure‐ and Ligand‐Based Virtual Screening Protocols Considering Hit List Complementarity and Enrichment Factors , 2010, ChemMedChem.
[33] Andreas Bender,et al. A Discussion of Measures of Enrichment in Virtual Screening: Comparing the Information Content of Descriptors with Increasing Levels of Sophistication , 2005, J. Chem. Inf. Model..
[34] Andreas Bender,et al. Diversity-oriented synthesis; a spectrum of approaches and results. , 2008, Organic & biomolecular chemistry.
[35] Andreas Bender,et al. Molecular Similarity Searching Using Atom Environments, Information-Based Feature Selection, and a Naïve Bayesian Classifier , 2004, J. Chem. Inf. Model..
[36] Andreas Bender,et al. How Similar Are Similarity Searching Methods? A Principal Component Analysis of Molecular Descriptor Space , 2009, J. Chem. Inf. Model..
[37] Andreas Bender,et al. Databases: Compound bioactivities go public , 2010 .
[38] M. Congreve,et al. Fragment-based lead discovery , 2004, Nature Reviews Drug Discovery.
[39] Jeffrey S. Albert,et al. Fragment‐Based Lead Discovery , 2010 .
[40] Naomie Salim,et al. Combination of Fingerprint-Based Similarity Coefficients Using Data Fusion , 2003, J. Chem. Inf. Comput. Sci..
[41] Herbert Köppen. Virtual screening - what does it give us? , 2009, Current opinion in drug discovery & development.
[42] Woody Sherman,et al. Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..
[43] Andreas Bender,et al. Alpha Shapes Applied to Molecular Shape Characterization Exhibit Novel Properties Compared to Established Shape Descriptors , 2009, J. Chem. Inf. Model..
[44] J. Irwin,et al. Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.
[45] Anthony E Klon. Bayesian modeling in virtual high throughput screening. , 2009, Combinatorial chemistry & high throughput screening.
[46] D. E. Clark. What has virtual screening ever done for drug discovery? , 2008, Expert opinion on drug discovery.
[47] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[48] Christian N Parker,et al. McMaster University Data-Mining and Docking Competition , 2005, Journal of biomolecular screening.